Unicycive Therapeutics Price Target Cut to $2.50/Share From $4.50 by HC Wainwright & Co.
Unicycive Therapeutics Price Target Cut to $2.50/Share From $4.50 by HC Wainwright & Co.
Unicycive Therapeutics價格目標下調至每股2.50美元，來自HC Wainwright & Co的4.50美元。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊